Therapeutic Efficacy of Tyrosine Kinase Inhibitors Treatment for Metastatic Renal Cell Carcinoma Using 18F-FDG PET/CT

Retrospective Epidemiological Study and Prognostic Factors of Renal Cell Carcinoma

Efficacy and Safety of Sorafenib Versus Supportive Care in Egyptian Advanced Hepatocellular Carcinoma Patients

Assessment of Outcomes of Maintenance Gemcitabine after Standard Chemotherapy in Metastatic Bladder Transitional Cell Carcinoma Patients

Treatment Outcome in Patients with Metastatic Non-Small Cell Lung Cancer at Presentation (Retrospective Study)

The Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy

Role of biological targetedtherapy in renal cell carcinoma

Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Sorafenib versus Radiotherapy

Anti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer

Partial Nephrectomy Versus Radical Nephrectomy for Localized Renal Masses: Critical Analysis of Oncological Outcome and Impact on the Renal Function